<DOC>
	<DOCNO>NCT02082548</DOCNO>
	<brief_summary>To determine whether comprehensive evaluation customize multilevel educational intervention increase rate use oral anticoagulant adherence persistence use patient atrial fibrillation . Our hypothesis difference use oral anticoagulant persistence patient control interventional group . There great change use oral anticoagulant one year cohort intervention site control sit . This due two factor : great initiation oral anticoagulant among patient treat baseline great persistence treatment treatment baseline</brief_summary>
	<brief_title>Clinical Trial Improve Treatment With Blood Thinners Patients With Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Patients age 18 paroxysmal , persistent permanent atrial fibrillation 12lead ECG show atrial fibrillation and/or one rhythm strip show atrial fibrillation least 2 week apart , due reversible cause ( like postCABG ) ) 2 . At least one traditional CHADS2 risk factor least two CHA2DS2 VASc risk factor Mechanical prosthetic valve Clinically unstable time enrollment ( ie , ongoing shock ) Terminal illness and/or comfort care Unable provide consent ( e.g . severe cognitive impairment ) Patients unable one year followup reason Clear absolute contraindication oral anticoagulation ( example , active bleeding recent lifethreatening bleed ICH )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>education</keyword>
	<keyword>educational intervention</keyword>
</DOC>